Price Alert

Miromatrix Medical Inc. (MIRO)

NASDAQ: MIRO · Real-Time Price · USD

3.39

0.02 (0.59%)

At close: Dec 12, 2023, 10:00 PM

Miromatrix Medical Statistics

Share Statistics

Miromatrix Medical has 27.42M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	27.42M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	n/a
Shares Floating	19.61M
Failed to Deliver (FTD) Shares	48
FTD / Avg. Volume	0.03%

Short Selling Information

The latest short interest is 11.66K, so 0.04% of the outstanding shares have been sold short.

Short Interest	11.66K
Short % of Shares Out	0.04%
Short % of Float	0.04%
Short Ratio (days to cover)	1

Valuation Ratios

The PE ratio is -2.07 and the forward PE ratio is null. Miromatrix Medical's PEG ratio is -0.02.

PE Ratio	-2.07
Forward PE	n/a
PS Ratio	65
Forward PS	n/a
PB Ratio	2.37
P/FCF Ratio	-2.23
PEG Ratio	-0.02

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Miromatrix Medical.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.52, with a Debt / Equity ratio of 0.14.

Current Ratio	5.52
Quick Ratio	5.36
Debt / Equity	0.14
Debt / EBITDA	-0.12
Debt / FCF	-0.13
Interest Coverage	-633.66

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$12.55K
Profits Per Employee	$-394.84K
Employee Count	76
Asset Turnover	0.03
Inventory Turnover	0.62

Taxes

Income Tax	47.84K
Effective Tax Rate	-0.16%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 0.01, so Miromatrix Medical's price volatility has been higher than the market average.

Beta	0.01
52-Week Price Change	n/a
50-Day Moving Average	2.87
200-Day Moving Average	1.76
Relative Strength Index (RSI)	75.32
Average Volume (20 Days)	163,022

Income Statement

In the last 12 months, Miromatrix Medical had revenue of 953.47K and earned -30.01M in profits. Earnings per share was -1.45.

Revenue	953.47K
Gross Profit	453.47K
Operating Income	-30.25M
Net Income	-30.01M
EBITDA	-29.91M
EBIT	-30.03M
Earnings Per Share (EPS)	-1.45

Full Income Statement

Balance Sheet

The company has 5.21M in cash and 3.55M in debt, giving a net cash position of 1.66M.

Cash & Cash Equivalents	5.21M
Total Debt	3.55M
Net Cash	1.66M
Retained Earnings	-104.01M
Total Assets	23.42M
Working Capital	12.23M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -26.68M and capital expenditures -1.06M, giving a free cash flow of -27.75M.

Operating Cash Flow	-26.68M
Capital Expenditures	-1.06M
Free Cash Flow	-27.75M
FCF Per Share	-1.34

Full Cash Flow Statement

Margins

Gross margin is 47.56%, with operating and profit margins of -3172.17% and -3147.22%.

Gross Margin	47.56%
Operating Margin	-3172.17%
Pretax Margin	-3142.21%
Profit Margin	-3147.22%
EBITDA Margin	-3137.2%
EBIT Margin	-3172.17%
FCF Margin	-2909.97%

Dividends & Yields

MIRO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for MIRO.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-3.66
Piotroski F-Score	3